Cantleyoside is primarily investigated for its potential anti-inflammatory and immunomodulatory properties. It has shown activity in suppressing pro-inflammatory cytokines, making it a candidate for research in autoimmune and chronic inflammatory diseases. Studies suggest it may influence signaling pathways such as NF-κB, which plays a central role in inflammation and cell survival. Due to its natural origin and structural features, it is also explored for antioxidant effects and possible neuroprotective applications. Its role in traditional medicine contexts supports ongoing interest in developing it as a lead compound for therapeutic agents, particularly in conditions involving oxidative stress and immune dysregulation.